Guyana - Re-Export of Vaccines for Human Use
Since 2012, Guyana Re-Export of Vaccines for Human Use rose 106.5% year on year. In 2017, the country was number 20 among other countries in Re-Export of Vaccines for Human Use with $4,133.96. Guyana is overtaken by Luxembourg, which was ranked number 19 at $4,706.78 and is followed by Cyprus with $2,725.4. United States lead the ranking with $21,386,560.62 in 2019, -18% compared to 2018. United Arab Emirates, Canada and Saudi Arabia respectively ranked number 2, 3 and 4 in this ranking. Guyana witnessed the best average annual growth at +106.5% per year, while Trinidad and Tobago witnessed the worst performance at -49.8% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2017 | 4,133.96 |
| 2016 | |
| 2015 | |
| 2014 | |
| 2013 |
Download all data from 1999 to 2017
How does Guyana rank in Re-Export of Vaccines for Human Use?
| # | 22 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
21,386,560.62 | 2019 | -18.0 % | -6.8 % | View data | |
| 2 |
#2
United Arab Emirates
|
7,990,507.15 | 2019 | +36.5 % | +27.7 % | View data | |
| 19 |
#19
Luxembourg
|
4,706.78 | 2019 | -6.2 % | +15.8 % | View data | |
| 20 |
#20
Guyana
|
4,133.96 | 2017 | NA | +106.5 % | View data | |
| 21 |
#21
Cyprus
|
2,725.40 | 2018 | +928.8 % | NA | View data | |